Furthermore, we identified a COVID-19-specific signature, characterized by altered concentrations of LysoPCaC18:2, beta-hydroxybutyric acid, Met SO, succinic acid, and carnosine, relative to INFA and RSV. The gene discussed is IFNA17; the disease is COVID-19.